Semi-Annual Consolidated Statement Of Cash Flows

Modalis Therapeutics Corporation - Filing #7312187

Concept 2024-01-01 to
2024-06-30
As at
2024-06-30
As at
2023-12-31
2023-01-01 to
2023-06-30
As at
2023-06-30
As at
2022-12-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-928,151,000 JPY
-975,925,000 JPY
Interest and dividends received
8,000 JPY
14,000 JPY
Interest paid
-2,057,000 JPY
-2,212,000 JPY
Income taxes paid
-1,210,000 JPY
-1,210,000 JPY
Net cash provided by (used in) operating activities
-931,410,000 JPY
-979,332,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-188,000 JPY
-37,830,000 JPY
Net cash provided by (used in) investing activities
-188,000 JPY
-37,830,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
256,143,000 JPY
615,005,000 JPY
Other, net
JPY
-293,000 JPY
Effect of exchange rate change on cash and cash equivalents
70,299,000 JPY
60,387,000 JPY
Net increase (decrease) in cash and cash equivalents
-605,155,000 JPY
-341,771,000 JPY
Cash and cash equivalents
1,278,281,000 JPY
1,883,437,000 JPY
2,591,391,000 JPY
2,933,162,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.